These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1728485)

  • 1. Early postoperative reduction of monoclonal antimyosin antibody uptake is associated with absent rejection-related complications after heart transplantation.
    Ballester M; Obrador D; Carrió I; Moya C; Augè JM; Bordes R; Martí V; Bosch I; Bernà-Roqueta L; Estorch M
    Circulation; 1992 Jan; 85(1):61-8. PubMed ID: 1728485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indium-111-monoclonal antimyosin antibody studies after the first year of heart transplantation. Identification of risk groups for developing rejection during long-term follow-up and clinical implications.
    Ballester M; Obrador D; Carrió I; Augé JM; Moya C; Pons-Lladó G; Caralps-Riera JM
    Circulation; 1990 Dec; 82(6):2100-7. PubMed ID: 2242534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of biopsy classification for rejection: relation to detection of myocardial damage by monoclonal antimyosin antibody imaging.
    Ballester M; Bordes R; Tazelaar HD; Carrió I; Marrugat J; Narula J; Billingham ME
    J Am Coll Cardiol; 1998 May; 31(6):1357-61. PubMed ID: 9581733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of indium-111 antimyosin scintigraphy in confirming myocardial injury in patients with anthracycline-associated left ventricular dysfunction.
    Valdés Olmos RA; ten Bokkel Huinink WW; ten Hoeve RF; van Tinteren H; Bruning PF; van Vlies B; Hoefnagel CA
    Ann Oncol; 1994 Sep; 5(7):617-22. PubMed ID: 7993837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of evolution of myocyte damage after human heart transplantation detected by indium-111 monoclonal antimyosin.
    Ballester-Rodés M; Carrió-Gasset I; Abadal-Berini L; Obrador-Mayol D; Bernà-Roqueta L; Caralps-Riera JM
    Am J Cardiol; 1988 Sep; 62(9):623-7. PubMed ID: 3046295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The diagnosis of rejection activity in the heart transplant by monoclonal antimyosin antibodies].
    Obrador D; Ballester M; Carrió I; Bernà L; Estorch M; Martí V; Padró JM; Caralps JM
    Rev Esp Cardiol; 1995; 48 Suppl 7():92-5. PubMed ID: 8775823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burden of myocardial damage in cardiac allograft rejection: scintigraphic evidence of myocardial injury and histologic evidence of myocyte necrosis and apoptosis.
    Puig M; Ballester M; Matías-Guiu X; Bordes R; Carrió I; Kolodgie FD; Pons C; García A; Aymat MR; Marrugat J; Brossa V; Campreciós M; Padró JM; Caralps JM; Virmani R; Prat J; Narula J
    J Nucl Cardiol; 2000; 7(2):132-9. PubMed ID: 10796002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence, evolving changes, and prognostic implications of myocardial damage detected in idiopathic and alcoholic dilated cardiomyopathy by 111In monoclonal antimyosin antibodies.
    Obrador D; Ballester M; Carrió I; Moya C; Bosch I; Martí V; Bernà L; Estorch M; Udina C; Marrugat J
    Circulation; 1994 May; 89(5):2054-61. PubMed ID: 8181129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of indium-111 antimyosin (Fab) imaging as a noninvasive surveillance method of human heart transplant rejection.
    De Nardo D; Scibilia G; Macchiarelli AG; Cassisi A; Tonelli E; Papalia U; Gallo P; Antolini M; Pitucco G; Reale A
    J Heart Transplant; 1989; 8(5):407-12. PubMed ID: 2795283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimyosin monoclonal antibodies for early detection of cardiac allograft rejection.
    Schuetz A; Fritsch S; Kemkes BM; Kugler C; Angermann C; Spes C; Anthuber M; Weiler A; Wenke K; Gokel JM
    J Heart Transplant; 1990; 9(6):654-61. PubMed ID: 2277304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of cardiac rejection in heterotopic heart transplantation using 111In-antimyosin.
    Nishimura T; Sada M; Sasaki H; Yutani C; Hayashi M; Amemiya H; Fujita T; Akutsu T; Manabe H
    Eur J Nucl Med; 1987; 13(7):343-7. PubMed ID: 3322830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of alcohol-induced myocardial damage detected by indium-111-labeled monoclonal antimyosin antibodies.
    Ballester M; Martí V; Carrió I; Obrador D; Moya C; Pons-Lladó G; Bernà L; Lamich R; Aymat MR; Barbanoj M; Guardia J; Carreras F; Udina C; Augé JM; Marrugat J; Permanyer G; Caralps-Riera JM
    J Am Coll Cardiol; 1997 Jan; 29(1):160-7. PubMed ID: 8996309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early detection of rejection and assessment of cyclosporine therapy by 111In antimyosin imaging in mouse heart allografts.
    Isobe M; Haber E; Khaw BA
    Circulation; 1991 Sep; 84(3):1246-55. PubMed ID: 1884451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocyte cell damage after administration of doxorubicin or mitoxantrone in breast cancer patients assessed by indium 111 antimyosin monoclonal antibody studies.
    Estorch M; Carrió I; Martínez-Duncker D; Berná L; Torres G; Alonso C; Ojeda B
    J Clin Oncol; 1993 Jul; 11(7):1264-8. PubMed ID: 8315423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ability of antimyosin scintigraphy monitoring to exclude acute rejection during the first year after heart transplantation.
    Hesse B; Mortensen SA; Folke M; Brodersen AK; Aldershvile J; Pettersson G
    J Heart Lung Transplant; 1995; 14(1 Pt 1):23-31. PubMed ID: 7727472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experiences with the application of monoclonal Indium-111 antimyosin scintigraphy in the diagnosis of rejection episodes following orthotopic heart transplantation].
    Hartmann A; Baum RP; Klepzig H; Huth A; Mondorf U; Herrmann G; Cieslinski G; Olbrich HG; Hör G; Krause E
    Z Kardiol; 1991 Jul; 80(7):454-8. PubMed ID: 1926991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of cardiac allograft rejection in dogs using indium-111 monoclonal antimyosin Fab.
    Addonizio LJ; Michler RE; Marboe C; Esser PE; Johnson LL; Seldin DW; Gersony WM; Alderson PO; Rose EA; Cannon PJ
    J Am Coll Cardiol; 1987 Mar; 9(3):555-64. PubMed ID: 3546461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimyosin imaging in cardiac transplant rejection.
    Johnson LL; Cannon PJ
    Circulation; 1991 Sep; 84(3 Suppl):I273-9. PubMed ID: 1884496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of noninvasive antimyosin imaging in infants and children with clinically suspected myocarditis.
    Martin ME; Moya-Mur JL; Casanova M; Crespo-Diez A; Asin-Cardiel E; Castro-Beiras JM; Diez-Jimenez L; Ballester M; Carrio I; Narula J
    J Nucl Med; 2004 Mar; 45(3):429-37. PubMed ID: 15001683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of doxorubicin cardiotoxicity in patients with sarcomas by indium-111-antimyosin monoclonal antibody studies.
    Carrió I; Lopez-Pousa A; Estorch M; Duncker D; Berná L; Torres G; de Andrés L
    J Nucl Med; 1993 Sep; 34(9):1503-7. PubMed ID: 8355070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.